Abstract

Clinical Outcomes and Health-Related Quality of Life (HRQoL) Among Randomized Clinical Trial (RCT)-Eligible and RCT-Ineligible Patients: Results from the Connect® MM Registry

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone: Update of the Phase 3 MAIA Trial
Aurore Perrot ...
Blood | VOL. 138
Aurore Perrot, et. al.Aurore Perrot ...
05 Nov 2021
Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Patients (Pts) with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of Griffin after 24 Months of Maintenance
Jacob P Laubach ...
Blood | VOL. 138
Jacob P Laubach, et. al.Jacob P Laubach ...
05 Nov 2021
Upfront Autologous Hematopoietic Stem-Cell Transplantation Improves Overall Survival in Comparison with Bortezomib-Based Intensification Therapy in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the Randomized Phase 3 EMN02/HO95 Study
...
Blood | VOL. 136
, et. al. ...
05 Nov 2020
The Burden of Relapsed/Refractory Multiple Myeloma: An Indirect Comparison of Health-Related Quality of Life Burden across Different Types of Advanced Cancers at Baseline and after Treatment Based on HORIZON (OP-106) Study of Melflufen Plus Dexamethasone
Paul G Richardson ... Joan Bladé
Blood | VOL. 134
Paul G Richardson, et. al.Paul G Richardson ... Joan Bladé
13 Nov 2019
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation.
Leslie S Kean ... Marcelo C Pasquini
Blood | VOL. -
Leslie S Kean, et. al.Leslie S Kean ... Marcelo C Pasquini
19 Jul 2024
Pediatric T-cell lymphoblastic lymphoma but not leukemia harbor TRB::NOTCH1 fusions with unfavorable outcome.
Marcel Te Vrugt ... Birgit Burkhardt
Blood | VOL. -
Marcel Te Vrugt, et. al.Marcel Te Vrugt ... Birgit Burkhardt
18 Jul 2024
Chronic graft-versus-host disease: Unresolved complication or ancient history?
Joseph A Pidala ... Bruce R Blazar
Blood | VOL. -
Joseph A Pidala, et. al.Joseph A Pidala ... Bruce R Blazar
15 Jul 2024
Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1+ acute lymphoblastic leukemia
Pierre Walczak ... Aurélie Cabannes-Hamy
Blood | VOL. -
Pierre Walczak, et. al.Pierre Walczak ... Aurélie Cabannes-Hamy
14 Jul 2024
View more papers